Related references
Note: Only part of the references are listed.Effect of influenza H1N1 neuraminidase V116A and I117V mutations on NA activity and sensitivity to NA inhibitors
Simone E. Adams et al.
ANTIVIRAL RESEARCH (2019)
Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness
Melissa A. Rolfes et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2018)
The use of plant lectins to regulate H1 N1 influenza A virus receptor binding activity
Nicolette Lee et al.
PLOS ONE (2018)
Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs
Ivan Kosik et al.
PLOS PATHOGENS (2018)
Antigenic and genetic characterization of influenza viruses circulating in Bulgaria during the 2015/2016 season
Neli Korsun et al.
INFECTION GENETICS AND EVOLUTION (2017)
Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial
Francisco M. Marty et al.
LANCET RESPIRATORY MEDICINE (2017)
Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010
A Kilander et al.
Eurosurveillance (2017)
A new pandemic influenza A(H1N1) genetic variant predominated in the winter 2010 influenza season in Australia, New Zealand and Singapore
I G Barr et al.
Eurosurveillance (2017)
Phenotypic and genotypic analysis of influenza viruses isolated from adult subjects during a phase II study of intravenous zanamivir in hospitalised subjects
Phillip J. Yates et al.
ANTIVIRAL RESEARCH (2016)
Genetic Analysis of Post-Pandemic 2010-2011 Influenza A(H1N1)pdm09 Hemagglutinin Virus Variants that Caused Mild, Severe, and Fatal Infections in Northern Greece
Angeliki Melidou et al.
JOURNAL OF MEDICAL VIROLOGY (2015)
Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial
Xavier Forns et al.
GASTROENTEROLOGY (2014)
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Ira M. Jacobson et al.
LANCET (2014)
A Recommended Numbering Scheme for Influenza A HA Subtypes
David F. Burke et al.
PLOS ONE (2014)
Defining Influenza A Virus Hemagglutinin Antigenic Drift by Sequential Monoclonal Antibody Selection
Suman R. Das et al.
CELL HOST & MICROBE (2013)
Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase
Jennifer L. McKimm-Breschkin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution
Bjorn F. Koel et al.
SCIENCE (2013)
In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir
Jennifer L. McKimm-Breschkin et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Molecular mechanism of the enhanced virulence of 2009 pandemic Influenza A (H1N1) virus from D222G mutation in the hemagglutinin: a molecular modeling study
Dabo Pan et al.
JOURNAL OF MOLECULAR MODELING (2012)
Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin
Yi Pu Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Escape mutants of pandemic influenza A/H1N1 2009 virus: Variations in antigenic specificity and receptor affinity of the hemagglutinin
Irina Rudneva et al.
VIRUS RESEARCH (2012)
Antibody Pressure by a Human Monoclonal Antibody Targeting the 2009 Pandemic H1N1 Virus Hemagglutinin Drives the Emergence of a Virus with Increased Virulence in Mice
Christopher D. O'Donnell et al.
MBIO (2012)
Clinical and virological course of infection with haemagglutinin D222G mutant strain of 2009 pandemic influenza A (H1N1) virus
Paul K. S. Chan et al.
JOURNAL OF CLINICAL VIROLOGY (2011)
Influenza A Virus Hemagglutinin Antibody Escape Promotes Neuraminidase Antigenic Variation and Drug Resistance
Scott E. Hensley et al.
PLOS ONE (2011)
Virulence-Associated Substitution D222G in the Hemagglutinin of 2009 Pandemic Influenza A(H1N1) Virus Affects Receptor Binding
Salin Chutinimitkul et al.
JOURNAL OF VIROLOGY (2010)
Predicting the Antigenic Structure of the Pandemic (H1N1) 2009 Influenza Virus Hemagglutinin
Manabu Igarashi et al.
PLOS ONE (2010)
Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus
Rui Xu et al.
SCIENCE (2010)
Glycosylation Focuses Sequence Variation in the Influenza A Virus H1 Hemagglutinin Globular Domain
Suman R. Das et al.
PLOS PATHOGENS (2010)
Variations in the Hemagglutinin of the 2009 H1N1 Pandemic Virus: Potential for Strains with Altered Virulence Phenotype?
Jianqiang Ye et al.
PLOS PATHOGENS (2010)
Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift
Scott E. Hensley et al.
SCIENCE (2009)
Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir
Mariana Baz et al.
ANTIVIRAL RESEARCH (2007)
Resistance of influenza viruses to neuraminidase inhibitors - a review
JL McKimm-Breschkin
ANTIVIRAL RESEARCH (2000)
A DNA transfection system for generation of influenza A virus from eight plasmids
E Hoffmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
